1 October 2012Patents

Indian Supreme Court to hear Novartis dispute over generic drugs

India’s highest court is set to hear a long-running dispute between Novartis and the country’s government, which has prevented the pharma company from patenting its cancer drug Gleevec.

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

UK-India trade deal is ‘missed opportunity’, say industry bodies

WATCH: Recent developments in design patent law

SEPs now searchable on WIPO’s global patent database

'Nothing can stand in the way of our work': Ukraine resumes IP system

Foley adds five-partner team from Perkins Coie and K&L Gates

WATCH: Finding a new balance in IP protection with trade secret protection

Optis v Apple: How the court calculated the royalty rate

Apple must pay Optis $700m-the biggest patent award in UK history

Indian Supreme Court to hear Novartis dispute over generic drugs

Editor's picks

Editor's picks

More articles